Accès gratuit
Volume 25, Mai 2016
Page(s) S37 - S43
Section Mise Au Point / Update
Publié en ligne 10 mars 2016
  • Blot S, Charles PE (2013) Fungal sepsis in the ICU: are we doing better? Trends in incidence, diagnosis, and outcome. Minerva Anestesiol 79:1396–405 [PubMed] [Google Scholar]
  • Kullberg BJ, Arendrup MC (2015) Invasive candidiasis. N Eng J Med 373:1445–56 [CrossRef] [Google Scholar]
  • Clancy CJ, Nguyen MH (2013) Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 56:1284–92 [CrossRef] [PubMed] [Google Scholar]
  • Oude Lashof AM, Rothova A, Sobel JD, et al (2011) Ocular manifestations of candidemia. Clin Infect Dis 53:262–8 [CrossRef] [PubMed] [Google Scholar]
  • Fernandez-Cruz A, Cruz Menarguez M, Munoz P, et al (2015) The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? A prospective cohort. Eur J Clin Microbiol Infect Dis 34:1543–9 [CrossRef] [PubMed] [Google Scholar]
  • Bassetti M, Marchetti M, Chakrabarti A, et al (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39:2092–106 [CrossRef] [PubMed] [Google Scholar]
  • Hidron AI, Edwards JR, Patel J, et al (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29:996–1011 [CrossRef] [PubMed] [Google Scholar]
  • Nagao M, Hotta G, Yamamoto M, et al (2014) Predictors of Candida spp. as causative agents of catheter-related bloodstream infections. Diagn Microbiol Infect Dis 80:200–3 [CrossRef] [Google Scholar]
  • Nucci M, Anaissie E (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959–67 [CrossRef] [PubMed] [Google Scholar]
  • Martin GS (2012) Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther 10:701–6 [CrossRef] [PubMed] [Google Scholar]
  • Martin GS, Mannino DM, Eaton S, et al (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Eng J Med 348:1546–54 [Google Scholar]
  • Colombo AL, Guimaraes T, Sukienik T, et al (2014) Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med 40:1489–98 [CrossRef] [PubMed] [Google Scholar]
  • Vincent JL, Bihari DJ, Suter PM, et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–44 [CrossRef] [PubMed] [Google Scholar]
  • Vincent JL, Rello J, Marshall J, et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–9 [CrossRef] [PubMed] [Google Scholar]
  • Kett DH, Azoulay E, Echeverria PM, et al (2011) Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39:665–70 [CrossRef] [PubMed] [Google Scholar]
  • Azoulay E, Cohen Y, Zahar JR, et al (2004) Practices in non-neutropenic ICU patients with Candida-positive airway specimens. Intensive Care Med 30:1384–9 [CrossRef] [PubMed] [Google Scholar]
  • Lortholary O, Renaudat C, Sitbon K, et al (2014) Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med 40:1303–12 [CrossRef] [PubMed] [Google Scholar]
  • Cohen Y, Karoubi P, Adrie C, et al (2010) Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. Crit Care Med 38:826–30 [CrossRef] [PubMed] [Google Scholar]
  • Bailly S, Bouadma L, Azoulay E, et al (2015) Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients. Am J Respir Crit Care Med 191:1139–46 [CrossRef] [PubMed] [Google Scholar]
  • Quenot JP, Binquet C, Kara F, et al (2013) The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care 17:R65 [CrossRef] [PubMed] [Google Scholar]
  • Azoulay E, Dupont H, Tabah A, et al (2012) Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med 40:813–22 [CrossRef] [PubMed] [Google Scholar]
  • Massanet P, Jung B, Molinari N, et al (2014) Antifungal treatment for suspected or proved candidiasis in the critically ill. Ann Fr Anesth Reanim 33:232–9 [CrossRef] [PubMed] [Google Scholar]
  • Piarroux R, Grenouillet F, Balvay P, et al (2004) Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 32:2443–9 [CrossRef] [PubMed] [Google Scholar]
  • Dupont H, Bourichon A, Paugam-Burtz C, et al (2003) Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 31:752–7 [CrossRef] [PubMed] [Google Scholar]
  • Montravers P, Dufour G, Guglielminotti J, et al (2015) Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis. Crit Care 19:70 [CrossRef] [PubMed] [Google Scholar]
  • Zappella N, Desmard M, Chochillon C, et al (2015) Positive peritoneal fluid fungal cultures in postoperative peritonitis after bariatric surgery. Clin Microbiol Infect 21:853.e1–e3 [CrossRef] [Google Scholar]
  • Savey A, Machut A (2013) Surveillance des infections nosocomiales en réanimation adulte, Réseau REA-Raisin, France, Résultats 2012. In: Surveillance des infections nosocomiales en réanimation adulte, Réseau REA-Raisin, France [Google Scholar]
  • Mimoz O, Lucet JC, Kerforne T, et al (2015) Skin antisepsis with chlorhexidine–alcohol versus povidone iodine–alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069–77 [CrossRef] [PubMed] [Google Scholar]
  • Leroy O, Gangneux JP, Montravers P, et al (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37:1612–8 [CrossRef] [PubMed] [Google Scholar]
  • Leroy O, Mira JP, Montravers P, et al (2010) Comparison of albicans vs. non-albicans candidemia in French intensive care units. Crit Care 14:R98 [Google Scholar]
  • Lortholary O, Desnos-Ollivier M, Sitbon K, et al (2011) Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 55:532–8 [CrossRef] [PubMed] [Google Scholar]
  • Bailly S, Maubon D, Fournier P, et al (2016) Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. — Trends over 10 years. J Infect 72:103–11 [CrossRef] [PubMed] [Google Scholar]
  • Bailly S, Leroy O, Montravers P, et al (2015) Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data. Intensive Care Med 41:1931–40 [CrossRef] [PubMed] [Google Scholar]
  • Bruyere R, Quenot JP, Prin S, et al (2012) Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU. BMC Infect Dis 14:385 [CrossRef] [Google Scholar]
  • Charles PE, Doise JM, Quenot JP, et al (2003) Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 29:2162–9 [CrossRef] [PubMed] [Google Scholar]
  • Poissy J, Sendid B, Damiens S, et al (2014) Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation. Crit Care 18:R135 [CrossRef] [PubMed] [Google Scholar]
  • Kollef M, Micek S, Hampton N, et al (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54:1739–46 [CrossRef] [PubMed] [Google Scholar]
  • Puig-Asensio M, Peman J, Zaragoza R, et al (2014) Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med 42:1423–32 [CrossRef] [PubMed] [Google Scholar]
  • Dupont H, Bourichon A, Paugam-Burtz C, et al (2003) Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 31:752–7 [CrossRef] [PubMed] [Google Scholar]
  • Montravers P, Dupont H, Gauzit R, et al (2006) Candida as a risk factor for mortality in peritonitis. Crit Care Med 34:646–52 [CrossRef] [PubMed] [Google Scholar]
  • Montravers P, Dupont H, Eggimann P (2013) Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis. Intensive Care Med 39:2226–30 [CrossRef] [PubMed] [Google Scholar]
  • Tissot F, Lamoth F, Hauser PM (2013) Beta-glucan antigenemia anticipates diagnosis of blood culture-negative intra-abdominal candidiasis. Am J Respir Crit Care Med 188:1100–9 [CrossRef] [PubMed] [Google Scholar]
  • Kett DH, Azoulay E, Echeverria PM et al (2011) Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39:665–70 [CrossRef] [PubMed] [Google Scholar]
  • Mora-Duarte J, Betts R, Rotstein C, et al (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Eng J Med 347:2020–9 [CrossRef] [Google Scholar]
  • Reboli AC, Rotstein C, Pappas PG, et al (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356:2472–82 [CrossRef] [PubMed] [Google Scholar]
  • Andes DR, Safdar N, Baddley JW, et al (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110–22 [CrossRef] [PubMed] [Google Scholar]
  • Cornely OA, Bassetti M, Calandra T, et al (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18:19–37 [CrossRef] [PubMed] [Google Scholar]
  • Bassetti M, Righi E, Ansaldi F, et al (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40:839–45 [CrossRef] [PubMed] [Google Scholar]
  • Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640–5 [CrossRef] [PubMed] [Google Scholar]
  • Paugam A, Ancelle T, Lortholary O, et al (2014) Longer incubation times for yeast fungemia: importance for presumptive treatment. Diagn Microbiol and Infect Dis 80:119–121 [CrossRef] [Google Scholar]
  • Parkins MD, Sabuda DM, Elsayed S, et al (2007) Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60:613–8 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.